Plantaglucid-health

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT PLANTAGLUCID-ZDOROVYE (PLANTAGLUCID-ZDOROVYE)

Composition:

Active substance: 1 sachet contains 1 g of plantaglucid;

Excipient: refined sugar.

Pharmaceutical form. Granules for oral solution.

Main physicochemical characteristics: granules from light brown with a greyish tint to dark brown with a greyish tint or dark grey in color, with a weak specific odor, sweet to taste.

Pharmacotherapeutic group. Agents affecting the gastrointestinal tract and metabolism. Drugs for the treatment of acid-related disorders. ATC code A02XX.

Pharmacological properties.

Pharmacodynamics.

A plant-derived agent, this is a preparation from the leaves of Plantago major, containing a mixture of polysaccharides.

Enhances gastric juice secretion and increases its acidity. Exerts anti-inflammatory, astringent, and antiseptic effects.

Pharmacokinetics.

Not studied.

Clinical characteristics.

Indications.

Hypochlorhydric gastritis (treatment and prevention of relapses); digestive disorders due to decreased gastric juice acidity.

Contraindications.

Hypersensitivity to the components of the drug; hyperacid gastritis, peptic ulcer of the stomach and duodenum, reflux esophagitis.

Interaction with other medicinal products and other forms of interaction.

Do not use simultaneously with antitussive agents and medicinal products that reduce sputum secretion.

Antacids and H2-histamine receptor blockers reduce the effectiveness of the drug.

Special precautions.

If a patient has an intolerance to certain sugars, consult a physician before taking this medication. Due to the presence of refined sugar, the drug may be harmful to teeth.

Since the drug contains refined sugar, this should be taken into account by patients with diabetes mellitus.

Use during pregnancy or breastfeeding.

There is no information available regarding the use of this medicinal product during pregnancy or breastfeeding.

Ability to influence reaction rate when driving or operating machinery.

Does not affect.

Method of administration and dosage.

Take orally, 20–30 minutes before meals, dissolving the dose in ¼ cup of warm water immediately before administration.

Adults and children aged 12 years and older: 1 sachet 2–3 times daily.

Children aged 6 to 12 years: ½ sachet 2–3 times daily.

The treatment duration during exacerbation of gastritis is 3–4 weeks.

For prevention of relapses, administer the same doses 1–2 times daily for 1–2 months.

The course and duration of treatment are determined individually by a physician.

Children. Information on the use of the drug in children under 6 years of age is limited.

Overdose.

In case of overdose, adverse effects may be intensified.

Treatment: discontinue the drug, symptomatic therapy.

Adverse reactions.

The drug is usually well tolerated. Occasionally possible heartburn, allergic reactions (including hyperemia, rash, itching, skin swelling).

Shelf life. 5 years.

Storage conditions. Store in original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging. 2 g in paired sachets No. 20 (2×10), No. 25 (2×12 and 1 sachet No. 1) in a box.

Availability. Over-the-counter.

Manufacturer. LIMITED LIABILITY COMPANY "CORPORATION "ZDOROV'YA".

Manufacturer's address and location of business activity.

Ukraine, 61013, Kharkiv region, city of Kharkiv, Shevchenka Street, building 22.